Abbott Laboratories Total Non-Operating Income/Expense 2010-2025 | ABT

Abbott Laboratories total non-operating income/expense for the twelve months ending March 31, 2025 was $223M, a 21.86% increase year-over-year.

  • Abbott Laboratories annual total non-operating income/expense for 2024 was $0.188B, a 1.08% increase from 2023.
  • Abbott Laboratories annual total non-operating income/expense for 2023 was $0.186B, a 432.14% decline from 2022.
  • Abbott Laboratories annual total non-operating income/expense for 2022 was $-0.056B, a 73.83% decline from 2021.